Page last updated: 2024-11-06

mitomycin and Amblyopia, Developmental

mitomycin has been researched along with Amblyopia, Developmental in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the safety and efficacy of photorefractive keratectomy (PRK) with Mitomycin C (MMC) for the treatment of severe pediatric anisometropia and amblyopia resistant to more conservative treatment modalities."7.78Pediatric PRK (PhotoRefractive Keratectomy) with Mitomycin C (MCC) for Persistent Anisometropic Amblyopia. A Case Report. ( Arnold, RW; Crawford, CM; Frazier, TC; Mazzoli, RA; Raymond, WR; Torres, MF, 2012)
"To evaluate the safety and efficacy of photorefractive keratectomy (PRK) with Mitomycin C (MMC) for the treatment of severe pediatric anisometropia and amblyopia resistant to more conservative treatment modalities."3.78Pediatric PRK (PhotoRefractive Keratectomy) with Mitomycin C (MCC) for Persistent Anisometropic Amblyopia. A Case Report. ( Arnold, RW; Crawford, CM; Frazier, TC; Mazzoli, RA; Raymond, WR; Torres, MF, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crawford, CM1
Frazier, TC1
Torres, MF1
Arnold, RW1
Mazzoli, RA1
Raymond, WR1

Other Studies

1 other study available for mitomycin and Amblyopia, Developmental

ArticleYear
Pediatric PRK (PhotoRefractive Keratectomy) with Mitomycin C (MCC) for Persistent Anisometropic Amblyopia. A Case Report.
    Binocular vision & strabology quarterly, Simms-Romano's, 2012, Volume: 27, Issue:4

    Topics: Amblyopia; Child; Humans; Lasers, Excimer; Mitomycin; Myopia; Photorefractive Keratectomy; Prospecti

2012